back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2020-06-05 10:04 Tx date 2020-05-27 |
$CORV
Correvio Pharma Corp. |
ADVANZ PHARMA Corp. Limited
3 - 10% Security Holder of Issuer
Holder: Mercury Pharma Group Limited (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
66,194,317 | ||
| Filed 2020-03-30 19:10 Tx date 2018-05-15 |
$CORV
Correvio Pharma Corp. |
Willms, Arthur Henry
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
79,000 | ||
| Filed 2020-03-30 14:50 Tx date 2018-05-15 |
$CORV
Correvio Pharma Corp. |
Willms, Arthur Henry
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
18,000 | ||
| Filed 2020-03-29 15:34 Tx date 2020-03-26 |
$CORV
Correvio Pharma Corp. |
Hunter, William L.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-1,345,500
-130,000 vol $10.35 each |
1,120,000 | |
| Filed 2020-03-29 15:32 Tx date 2020-03-26 |
$CORV
Correvio Pharma Corp. |
Sachot, Hugues
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-338,445
-32,700 vol $10.35 each |
0 | |
| Filed 2020-03-29 15:30 Tx date 2020-03-26 |
$CORV
Correvio Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-338,445
-32,700 vol $10.35 each |
425,000 | |
| Filed 2020-03-29 15:27 Tx date 2020-03-26 |
$CORV
Correvio Pharma Corp. |
Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-338,445
-32,700 vol $10.35 each |
425,000 | |
| Filed 2020-03-24 15:06 Tx date 2018-05-15 |
$CORV
Correvio Pharma Corp. |
Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
12,991 | ||
| Filed 2020-03-16 15:53 Tx date 2018-03-15 |
$CORV
Correvio Pharma Corp. |
Sachot, Hugues
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
32,700 | ||
| Filed 2020-03-16 15:50 Tx date 2019-03-14 |
$CORV
Correvio Pharma Corp. |
Hunter, William L.
4 - Director of Issuer
Holder: Cathryn Hunter (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
28,935 | ||
| Filed 2020-03-16 15:49 Tx date 2019-03-14 |
$CORV
Correvio Pharma Corp. |
Hunter, William L.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
991,946 | ||
| Filed 2020-03-16 15:48 Tx date 2018-05-15 |
$CORV
Correvio Pharma Corp. |
Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
14,500 | ||
| Filed 2019-12-13 13:10 Tx date 2019-12-13 |
$CORV
Correvio Pharma Corp. |
Meyer, Robert James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,368
-8,420 vol $0.40 each |
0 | |
| Filed 2019-08-15 16:24 Tx date 2019-08-13 |
$CORV
Correvio Pharma Corp. |
O'Shea, William James
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-164,386.02
-19,974 vol $8.23 each |
99,000 | |
| Filed 2019-08-15 16:21 Tx date 2019-08-13 |
$CORV
Correvio Pharma Corp. |
Grant, Sheila
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-205,750
-25,000 vol $8.23 each |
457,700 | |
| Filed 2019-08-15 16:11 Tx date 2019-08-13 |
$CORV
Correvio Pharma Corp. |
Hunter, William L.
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-823,000
-100,000 vol $8.23 each |
1,250,000 | |
| Filed 2019-08-15 15:57 Tx date 2019-08-13 |
$CORV
Correvio Pharma Corp. |
McMasters, David D.
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-164,600
-20,000 vol $8.23 each |
457,700 | |
| Filed 2019-06-27 18:57 Tx date 2019-06-25 |
$CORV
Correvio Pharma Corp. |
O'Shea, William James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$57,750
+25,000 vol $2.31 each |
118,974 | |
| Filed 2019-06-27 18:54 Tx date 2019-06-25 |
$CORV
Correvio Pharma Corp. |
Meyer, Robert James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,200
+20,000 vol $2.31 each |
75,100 | |
| Filed 2019-06-27 18:48 Tx date 2019-06-25 |
$CORV
Correvio Pharma Corp. |
Glickman, Richard
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,000
+20,000 vol $3.00 each |
75,000 |